Achillion Pharmaceuticals has announced that the US Food and Drug Administration (FDA) have decided not to lift its clinical hold on sovaprevir, the company’s experimental treatment for the hepatitis C virus. Read our coverage on the story here:
Achillion’s hep C drug remains in limbo - Hepatitis C Trust
Achillion’s hep C drug remains in limbo
Written by
Hep_C_News_team
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Hep c :-/
Hello
Just wondering I have hep c, have a scan on the 25/4/19 as my liver in larged...my bf was...
Hep c medicine
Hello, new on here and worried about my husband who has hep c, we received a letter today that the...
Hep c appt
Does any one know what happens at the first hep c appt,i have a letter that doesnt say what will be...
Hep c new treatment
Hi guys am due to start the new treatment for hep c on Wednesday can anyone tell me if and what the...
Hep c (actual pictures)
These are the evil hep c critters our treatment are killing.